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Objective: To determine the clinical effectiveness of an exercise programme on self-reported hand
activity performance in people with hand osteoarthritis (OA).
Design: In this randomized, controlled trial, participants with physician-conﬁrmed hand OA were
randomly allocated to a 12-week exercise intervention (group- and home-based) or usual care. The
primary outcome was self-reported hand activity performance at 3 months measured by the Functional
Index for Hand Osteoarthritis (FIHOA) and a patient-generated measure of disability, the Patient-Speciﬁc
Functional Scale (PSFS).
Results: Of 130 randomized participants (mean age 66 (standard deviation (SD) 9); female 90%), 120 (92%)
and 119 (92%) completed the 3- and 6-month follow-ups. The adjustedmean difference for the exercise vs
control group was 0.5 points (95% conﬁdence interval (CI) 1.6, 0.6) for the FIHOA score (0e30 scale,
0 ¼ best) and 0.9 points (95% CI 0.1, 1.7) for the PSFS score (0e10 scale, 10 ¼ best). Small signiﬁcant mean
differences in favour of the intervention group were found for hand pain, hand stiffness and disease
activity, whereas no mean differences were observed in hand dexterity or maximal grip strength. A
signiﬁcantly larger proportion in the intervention (46%) vs control group (16%) fulﬁlled the Outcome
Measures in Rheumatological Clinical Trials-Osteoarthritis Research Society International (OMERACT-
OARSI) responder criteria at 3months (OR¼ 4.4, 95% CI 1.9, 10.2). At the 6-month follow-up, therewere no
signiﬁcant group differences in any outcome.
Conclusions: The exercise programme was well tolerated among people with hand OA, but resulted only
in small, beneﬁcial short-term improvements on self-reported measures and not on most performance-
based tests. Future studies should address optimal grip strength exercises and dosage.
Trial registration: ClinicalTrials.gov registration number: NCT01245842.
© 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Hand osteoarthritis (OA) may lead to considerable pain in and
around affected joints and a reduction in joint mobility and grip
strength1,2. This can in turn have a substantial impact on hands to: N. Østerås, National
epartment of Rheumatology,
Oslo, Norway. Tel: 47-92-08-
Østerås), k.b.hagen@medisin.
no (M. Grotle), anne-lene.
ter.mowinckel@diakonsyk.no
n).
ternational. Published by Elsevier Lfunction andmay result in activity and participation limitations and
reduced work ability2,3. Previous research has showed that the grip
strength in people with hand OA was reduced to less than 60% of
normal strength values2.
In the absence of disease-modifying interventions, non-
pharmacological approaches like information, exercise and
weight-control are considered to be core treatment for all people
with OA4. While a considerable amount of research demonstrate
positive effects of exercise on pain and function in lower limb OA5,
the evidence for the effectiveness of exercises in people with hand
OA is scarce and of poor quality6,7. While the European League
Against Rheumatism (EULAR) guideline8 has included exercise
regimen in their recommendations for treatment of hand OA, thetd. All rights reserved.
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(ACR)9 has not. The EULAR recommendation is based on a small
randomized controlled trial (RCT) comparing a joint protection
programme and ﬂexibility exercises vs hand OA information
alone10. It is, however, underscored that the direct evidence for the
clinical effectiveness of exercise is lacking, and that robust RCTs are
needed. Among the few clinical exercise trials that have been
published, ﬁve have evaluated the effect of exercise in addition to
patient education and/or instructions in joint protection and
splints10e14, while one pilot RCT compared two different thumb
exercise regimen15, and only two studies of lower quality (a small
RCT and one cross-over study) have evaluated the effect of exercise
alone16,17. The study results vary largely from no effect13,14 to small
effects for either pain, function or strength10,12,16,17. Further, there
was only small muscle strength improvements from exercise pro-
grammes designed to improve strength16,17, whereas a programme
with ﬂexibility exercises resulted in 25% increased grip strength10.
Hence, there is very limited and conﬂicting evidence for the effect
of exercises in hand OA, and high-quality RCTs on the efﬁcacy of
exercise as a single treatment element are needed7,13.
The aim of this studywas to investigate clinical effectiveness of a
12-week exercise programme with usual care on self-reported
hand activity performance among people with hand OA. This is
one of the ﬁrst large-scale RCT studies that examine the effective-
ness of exercise therapy alone.
Method
Study design
The study was an assessor-blinded, parallel-group RCT with two
arms, and follow-up at 3 and 6 months. Details of the trial devel-
opment, design, and conduct have been published18. The protocol
adhered to the SPIRIT 2013 Statement for standard protocol items
in clinical trials19 and the CONSORT guidelines for non-
pharmacological interventions20,21, and was designed to conform
to the principles of good clinical practice and the Declaration of
Helsinki. The study was approved by the Regional Committee for
Medical and Health Research Ethics (Ref. no: 2010/727a) and the
Data Inspectorate. The study participants received written and oral
information about the study, and written consent was collected
prior to the baseline data collection.
Setting and participants
The study was conducted in a primary health-care service close
to Oslo and at Diakonhjemmet Hospital, Oslo, Norway. One occu-
pational therapist at each location led the group exercises.
Participants were recruited from two OA cohorts:
1. The Musculoskeletal pain in Ullensaker STudy e Osteoarthritis
cohort (MUST OA): people with OA in their hands, hips and/or
knees derived from a population-based postal survey sent to all
inhabitants between 40 and 79 years of age (n ¼ 12,370) in
Ullensaker Municipality in 2010e2011. Among the 1019 who
self-reported OA, 630 attended a comprehensive clinical ex-
amination at Diakonhjemmet hospital in 2010e201322.
2. The Oslo Hand OA cohort: patients at Diakonhjemmet Hospital
between 50 and 70 years of age enrolled in 2000e2002
(n ¼ 209)23 with a follow-up examination in 2009 (n ¼ 128).
The inclusion criteriawere: meeting the ACR criteria for features
of hand OA or uni-/bilateral OA in the ﬁrst carpometacarpal (CMC1)
joint, and a Functional Index for Hand OsteoArthritis (FIHOA)24
score 5. Those who had an inﬂammatory rheumatic disease(e.g., rheumatoid arthritis, polymyalgia rheumatica), had received
steroid injections in the past 2 months, had recently experienced
severe trauma or recently underwent OA surgery or other major
surgery were excluded along with people with cognitive dysfunc-
tion or language problems.
Theﬁrst authorcheckedeligibility (e.g., physician-conﬁrmedACR
criteria, CMC1 OA, comorbidity) by screening previously collected
cohort data. Eligible persons received written information and a
request to participate, and those willing, were screened by tele-
phone to ensure recruitment according to all inclusionandexclusion
criteria. Baseline measurements took place regularly between
January 2011 and January 2013 with 8e19 participants each time.
Randomization and blinding
The randomization schedule was prepared by the study
biostatistician (PM) using a computer-generated random numbers
table and the use of random permuted blocks of 10. Consecutively
numbered and sealed opaque envelopes were prepared by an in-
dependent staff member and opened in sequence after the partic-
ipant had completed all baseline measurements. The outcome
assessors and the statistician were blinded to group allocation, and
participants were requested not to disclose details about their
group allocation with the outcome assessor (physiotherapists and
occupational therapists) (Supplementary Data 1).
Usual care
The control group received no particular attention, referral or
treatment from the project group in this study. They groups were
allowed to receive ‘usual care’ for their hand OA, but in Norway this
is limited to general practitioner visits only, and very infrequently, a
referral to a consultation with an occupational therapist in sec-
ondary care.
The intervention
The development of the intervention adhered to the framework
for the design and evaluation of complex interventions25 and was
based on synthesized evidence from three key sources carrying
equal weight: research evidence from a systematic review7, clinical
expertise and client knowledge26. The American College of Sports
Medicine's recommendations for developingmuscular strength and
ﬂexibility in older frail adults27 were employed for exercise dosage.
The intervention group received the exercise intervention aiming to
improve grip strength, thumb stability and maintain ﬁnger range of
motion (Supplementary Data 2, Table I). All exercises were practiced
with an occupational therapist during the ﬁrst group session, which
took place immediately post-randomization. The participants were
instructed to perform the exercise programme 3 times weekly as
one set of 10 repetitions in weeks 1e2 and 15 repetitions in weeks
3e12 with moderate to vigorous intensity. The programme was
mainly home-based, but included also four group exercise sessions
(weeks 1e3, 8). In the 8 weeks with no group session, a weekly
telephone call was made by one of the co-authors (ALSS). The main
purpose of the telephone calls was to ensure adherence to the ex-
ercise programme as evidence of such effects has been reported
previously28. After 3 months the intervention group could decide to
continue or discontinue the exercise programme.
Outcome measures
All outcome measures were collected at baseline, 3 months
(post-intervention, primary endpoint) and 6 months by a ques-
tionnaire and a clinical assessment. The primary outcome measure
Table I
Exercise programme for people with hand osteoarthritis
No. Exercise illustration Instructions*
1. Shoulder extension: Sit on an armless chair, knees slightly ﬂexed, and heels on the ﬂoor.
Start position: hands partly pronated (thumb up), close to the knees. Pull the exercise band
back, as the hands follow the thigh to the iliac crest.
2. Biceps curl: Stand with the feet shoulder width apart, arms hanging down. Hands
are supinated (thumb laterally). Bend both elbows, pulling the exercise band towards
the shoulders.
3. Shoulder ﬂexion: Stand with the feet shoulder width apart, arms hanging down. Hands
are pronated (thumb medially). Keep the elbows extended and lift the arms to face level.
4. Make an “O-sign”: Keep the thumb IP and MCP joints slightly ﬂexed throughout. First, open
the hand as if grabbing a bottle. Bring the index ﬁnger tip to the thumb tip, keeping the MCP,
PIP and DIP joints ﬂexed. Open the hand again (“grab the bottle”). Repeat with the third,
fourth and ﬁfth ﬁngers.
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Table I (continued )
No. Exercise illustration Instructions*
5. Roll into a ﬁst: First, ﬂex the second to ﬁfth DIPs and PIPs only (keep the MCPs extended).
Then ﬂex the MCPs. Hold for 5 s. Reverse: extend the MCPs only, then the PIPs and DIPs.
6. Thumb abduction/extension: Put one or more small elastic band(s) around the ﬁrst to
ﬁfth proximal phalanges. Rest the loose ﬁst, pronated, on a ﬂat surface. Keep the thumb
MCP and IP joints ﬂexed and abduct/extend the thumb. Hold for 5 s.
7. Grip strength: Squeeze a pipe insulation tube as hard as possible (isometric hold)
for 10 s.
8. Finger stretch: Lay the right hand on a ﬂat surface. Use the left hand to apply ﬁrm pressure
for 30 s stretching the second to ﬁfth PIP and DIP joints. Repeat 2 times for each hand.
If the ﬁnger joints are painful: stretch one ﬁnger at a time; place the second to fourth
ﬁnger tips (opposite hand) between the ﬁnger joints of the second ﬁnger; press for 30 s.
* After a few minutes warm-up period of rubbing the hands together and doing arm swings, the participants were instructed to perform exercises 1e7 with moderate to
vigorous intensity in 10 repetitions for weeks 1e2 and 15 repetitions for weeks 3e12. Exercise 8: 3 repetitions.
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Functional Index for Hand OsteoArthritis24 (FIHOA; 10 hand activ-
ities, total score 0e30 (30 ¼ very poor hand activity performance))
and interview administration of the Patient-Speciﬁc Function
Scale29 (PSFS) 11-point numeric rating scale (NRS), 3e5 self-selected
hand activities that theyare unable to do orhavedifﬁculty doing as a
result of their hand OA (0 ¼ “Unable to perform activity” e
10 ¼ “Able to perform activity at pre-injury/-disease level”). Good
validity and reliability results for the PFSS were recently demon-
strated, and the study authors considered the PSFS to be a valuable
supplement to existing instruments in measuring activity limita-
tions in people with hand OA30. Only the scores for the ﬁrst hand
activity were used, as it is reported to have the highest reliability31.
Secondary outcome measures included self-reported hand pain
(NRS 0e10), hand stiffness (NRS 0e10), patient global assessment
of disease activity (NRS 0e10) and patient global assessment of
disease activity affecting activities of daily living (NRS 0e10).
Additionally, the number of “responders” in the two groups was
compared using the OutcomeMeasures in Rheumatological Clinical
Trials (OMERACT) and Osteoarthritis Research Society International
(OARSI) responder criteria32. Maximal grip strength was measured
using a Jamar Dynamometer (in second handle position), and hand
dexterity was assessed by the Moberg Pick-up Test33. The thumb
web space was measured with a Grip Size instrument including 12
transparent plexiglass cylinders, with a diameter 1e12 cm. The
largest size, in which the assessor could see full contact between
the cylinder and the total arch of the participant's thumb and
second digit, was recorded for each hand.Various values for the minimal clinically important change
(MIC) in PSFS scores have been given for different conditions, but
are often found to be approximately 2 points34. In a recent study on
patients with upper extremity problems, a MIC of 1.2 points was
found35. For FIHOA the MIC is not known, but the smallest
detectable change (SDC) has been reported to be 5.6 points36. AMIC
of 1e2 points for NRS on pain has previously been reported for
patients with neck pain, low back pain and shoulder pain37e39. To
the best of our knowledge, the MIC value for grip strength has not
previously been investigated. In patients undergoing haemodialysis
and MS patients, the standard error of measurement (S.E.M.) was
1.4e1.8 kg, while the SDC90% was 3.4 kg40,41.
Participants in the exercise group recorded the number and
length of exercise sessions and pain following each exercise session
(NRS 0e10) in an exercise diary. The total number of registered
exercise sessions was calculated, and high adherencewas deﬁned as
attendance at more than 75% (three of four) of scheduled group
exercise sessions and 60% (22 of the prescribed 36) of registered
home exercise sessions in the exercise diary. Information on adverse
events related to the exercise interventionwas registered during the
weekly telephone call or captured from the exercise diary.
Sample size
The primary outcome measure FIHOA sum score (range: 0e30
points) was used to estimate sample size. Using a MIC of three
points (10%) (sd 6.2), with a signiﬁcance level of 0.05 (2-tailed) and
a power of 80%, we estimated that 68 participants were needed in
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75 participants in each group. For PSFS (MIC: 2 points, sd: 2.2) a
corresponding sample size calculation would result in 22 partici-
pants per group.
Statistical analyses
Mean and standard deviation (SD) were used to describe the
participants and their characteristics at baseline for continuous
variables, whereas counts with percentages were used for cate-
gorical variables. Group comparisons were performed by Chi-
square for categorical data and independent sample t-tests for
continuous data. Descriptive statistics were presented for each
group as the mean values (95% conﬁdence intervals (CI)) at 0, 3 and
6months. Differences inmean values with 95% CI at 3 and 6months
were analysed using analysis of covariance (ANCOVA), adjusting for
baseline levels of the outcome measure. Model assumptions were
checked by standard diagnostic plots. The intention-to-treat prin-
ciple (ITT) was followed in the primary analyses of data, though per
protocol analyses were also done. Improvements in the interven-
tion and control group based on the perceived ratings of change orFig. 1. Flow dthe OMERACT-OARSI responder criteria32 were compared using
logistic regression and presented as odds ratios with a 95% CI. An
association between the number of exercise sessions and changes
in grip strength was analysed with linear regression. No missing
values were imputed, and no statistical adjustment was made for
multiple testing. All analyses were performed by using IBM SPSS
Statistics software version 21.
Results
Of 183 eligible, 130 (71%) males and females agreed to partici-
pate and were included, and 120 (92%) and 119 (92%) participants
completed the 3- and 6-month follow-ups, respectively (Fig. 1).
Approximately two-thirds of the study sample was recruited from
the population-based OA cohort, and the randomisation ensured a
similar distribution from the two cohorts between the intervention
and control groups. The mean age was 66 years, 90% were females,
and the mean body mass index (BMI) was 27 (Table II). Eligible
persons who did not participate (n ¼ 53) were comparable to the
study sample regarding baseline characteristics. The attrition rate
at the 3-month follow-up was signiﬁcantly higher (P ¼ 0.05) in theiagram.
Table II
Baseline characteristics of participants stratiﬁed by study group
Intervention
group (n ¼ 65)
Control
group (n ¼ 65)
MUST cohort/Oslo HOA cohort, n 46/19 46/19
Females, n (%) 58 (89) 59 (91)
Age, mean (SD) 67 (8) 65 (9)
BMI*, mean (SD) 28 (5) 27 (4)
Marital status, n (%)
Married 37 (57) 46 (71)
Divorced/separated 9 (14) 14 (22)
Widowed 15 (23) 4 (6)
Single 3 (5) 0 (0)
Occupational status, n (%)
Working full-time or part-time 9 (14) 18 (28)
Sick-listed 1 (2) 1 (2)
Disability pensioner 16 (25) 10 (15)
Age retired 39 (60) 36 (55)
Education, n (%)
Lower secondary school 15 (23) 9 (14)
Upper secondary school 28 (44) 36 (56)
University 1e4 years 16 (25) 16 (25)
University >4 years 5 (8) 3 (5)
Self-reported hip or knee OA, n (%)
Hip 25 (39) 30 (46)
Knee 26 (40) 33 (51)
Fulﬁlment of ACR criteria for hand OA, n (%) 59 (91) 59 (91)
Years with OA diagnosis, mean years (SD) 11 (9) 12 (7)
Comorbidities, n (%)
Other rheumatic diseasey 8 (13) 10 (15)
Other chronic non-rheumatic disease 23 (35) 21 (33)
No other rheumatic or chronic disease 36 (56) 37 (58)
Severe mental distressz, n (%) 11 (17) 25 (39)
* BMI: Body Mass Index (kg/m2).
y Other rheumatic diseases include: psoriasis, Sjogren's syndrome and
ﬁbromyalgia.
z GHQ20: General Health Questionnaire 20 items (bimodal scoring 0-0-1-1, range
0e20, 4 ¼ severe distress).
Table IV
Mean values at baseline, 3 and 6 months and adjusted mean differences for the
secondary outcome measures
Control group
n ¼ 55e65
mean (SD)
Exercise group
n ¼ 48e65
mean (SD)
Adjusted mean
difference (95% CI)
Hand pain, NRS 0e10*
Baseline 3.9 (1.8) 4.2 (2.1)
3 months 4.4 (2.0) 3.7 (2.1) 0.9 (1.4, 0.4)*
6 months 4.3 (2.1) 4.3 (2.3) 0.2 (0.8, 0.3)
Hand stiffness, NRS 0e10*
Baseline 4.5 (1.8) 4.6 (2.2)
3 months 4.5 (1.9) 3.9 (2.1) 0.7 (1.2, 0.1)*
6 months 4.7 (2.0) 4.4 (2.1) 0.3 (0.9, 0.3)
Patient global assessment of disease activity, NRS 0e10*
Baseline 4.3 (1.8) 4.3 (1.9)
3 months 4.6 (1.8) 3.7 (2.0) 1.0 (0.5, 1.5)*
6 months 4.1 (1.9) 4.2 (2.2) 0.1 (0.5, 0.7)
Patient global assessment of disease activity affecting ADL, NRS 0e10*
Baseline 3.9 (2.0) 4.1 (2.0)
3 months 4.1 (1.9) 3.6 (2.0) 0.7 (1.3, 0.2)*
6 months 3.8 (2.0) 3.8 (2.2) 0.2 (0.8, 0.4)
Maximal grip strength e right hand, kg
Baseline 24.0 (8.0) 22.7 (8.3)
3 months 23.7 (8.6) 23.5 (7.7) 0.6 (0.8, 2.0)
6 months 22.4 (8.6) 22.1 (8.2) 1.4 (0.3, 2.9)
Maximal grip strength e left hand, kg
Baseline 22.7 (9.1) 21.0 (9.0)
3 months 22.3 (9.5) 22.3 (8.1) 0.7 (0.8, 2.2)
6 months 21.5 (9.3) 20.0 (9.0) 0.1 (1.6, 1.7)
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baseline characteristics of the drop-outs in the intervention group
were similar to the rest of the group, except that they were more
likely to be separated/divorced/widowed (P ¼ 0.007). The recruit-
ment rate corresponded to a power of 74% with the FIHOA as pri-
mary outcome measure.
Primary and secondary outcomes
The ITT analysis of the primary outcomes at 3 months showed
clinical effectiveness of the intervention on hand activity perfor-
mance as measured by the self-selected activity in PSFS, but not for
the standardized FIHOA (Table III). Compared to the control group,Table III
Mean values at baseline, 3 and 6 months and adjusted mean differences for the
primary outcome measures
Control group
n ¼ 58e64
mean (SD)
Exercise group
n ¼ 57e65
mean (SD)
Adjusted mean
difference (95% CI)
FIHOA*, 0e30
Baseline 9.8 (4.7) 10.8 (5.0)
3 months 10.0 (4.8) 10.3 (4.7) 0.5 (1.6, 0.6)
6 months 10.5 (4.9) 10.9 (5.4) 0.5 (1.9, 0.8)
PSFSy, NRS 0e10
Baseline 3.9 (2.3) 3.5 (2.4)
3 months 4.3 (2.3) 5.1 (2.5) 0.9 (0.1, 1.7)*
6 months 4.4 (2.6) 4.3 (2.5) 0.1 (0.7, 1.0)
*P ¼ 0.031, ANCOVA, group as covariate and adjusted for baseline values.
* FIHOA is scored from 0 (good performance of hand activities) to 30 (very poor
performance of hand activities).
y PSFS, 11-point NRS: 0 (Unable to perform activity)e 10 (Able to perform activity
at pre-injury/-disease level).the intervention group reported signiﬁcantly less hand pain and
hand stiffness, as well as a lower patient global assessment of dis-
ease activity and disease activity affecting daily activities. Thumb
web space in the left hand was also signiﬁcantly better for the
intervention compared to the control group, whereas no difference
was found for hand dexterity ormaximal grip strength (Table IV). At
3 months, 26 (46%) participants in the intervention group and 10
(16%) in the control group fulﬁlled the OMERACT-OARSI responder
criteria (OR¼4.4, 95%CI 1.9,10.2). At6months,17 (30%) and17 (28%)
participants fulﬁlled the responder criteria (ns) in the
intervention and control group, respectively. At the 6-month follow-
up, there were no statistically signiﬁcant differences between the
two groups in any of the outcome measures (Tables III and IV).
In relation to smallest detectable and clinically important
changes, 14% (n ¼ 8) vs 6% (n ¼ 4) decreased their FIHOA scores >5
in the intervention vs control group, respectively, whereas the
proportions increasing PSFS scores 2 were 43% (n ¼ 24) vs 26%
(n ¼ 17), respectively. For pain, stiffness and patient global, the
proportions with score improvements >1 ranged 42e50% vs
26e40% for the intervention vs the control group, respectively, andHand dexterity e right hand, secondsy
Baseline 15.3 (4.6) 15.4 (5.4)
3 months 15.5 (6.0) 14.2 (4.8) 1.0 (2.3, 0.3)
6 months 15.4 (7.2) 16.2 (10.2) 0.7 (1.2, 2.6)
Hand dexterity e left hand, secondsy
Baseline 15.9 (5.2) 16.1 (5.7)
3 months 15.9 (5.6) 15.7 (9.0) 0.7 (1.8, 0.5)
6 months 15.8 (7.3) 18.0 (17.4) 0.8 (0.9, 2.5)
Thumb web space e right hand, 0e12z
Baseline 5.3 (1.5) 4.9 (1.3)
3 months 6.1 (2.0) 6.1 (1.5) 0.2 (0.4, 0.8)
6 months 5.4 (2.1) 5.8 (1.5) 0.5 (0.1, 1.1)
Thumb web space e left hand, 0e12z
Baseline 5.4 (1.6) 5.0 (1.5)
3 months 5.6 (2.0) 6.1 (1.6) 0.7 (0.1, 1.2)*
6 months 5.5 (2.0) 5.8 (2.0) 0.0 (0.0, 0.0)
*P < 0.05, ANCOVA, group as covariate and adjusted for baseline values.
* 11-point NRS: 0 (cannot do) e 10 (no problems).
y Moberg Pick-up test33.
z Grip Size instrument including 12 transparent plexiglass cylinders, diameter
1e12 cm, largest size with full contact between the cylinder and the total arch of the
thumb and second digit.
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>4.3 kg, respectively. The differences in proportions were signiﬁ-
cant for pain (P ¼ 0.024) and right-hand grip strength (P ¼ 0.018).
Exercise adherence
At the 3- and 6-month follow-ups, four and ﬁve participants in
the control group, respectively, reported that they had done hand
exercises now and then over the past 3 months. At 6 months, 71%
(n¼ 42) in the intervention group reported that they had continued,
or partly continued, with the exercise programme, with a median
number of two sessions in the past week. In total, 53 of 57 exercise
diaries were returned (failed to ﬁll in: n ¼ 2, lost due to moving
house: n ¼ 2), and 25 participants had recorded 35 or 36 of total 36
exercise sessions, whereas 50 had recorded 22 sessions. Of these
50, all but one had participated in 3 group exercise sessions, and
were characterized with “high adherence”. The mean duration per
session was 23 (SD 7) minutes in week 1 and 19 (SD 6) minutes in
week 12. The mean number of telephone calls per participant was
seven, and the mean duration per call was 3 min and 25 s.
Per protocol analyses
Per protocol analyses were performed, excluding 19 participants
in the intervention group (not received intervention n ¼ 6, corti-
costeroid injection n ¼ 1, rheumatoid arthritis n ¼ 1, low/unknown
intervention concordance n ¼ 11) and one in the control group
(language difﬁculties). The estimates did not change except for PSFS
adjusted mean difference at 3 months, which was no longer sig-
niﬁcant (B¼ 0.8, 95% CI 0.00,1.64), whereas the right handmaximal
grip strength adjusted mean difference at 6 months was signiﬁcant
(B ¼ 1.8 95% CI 0.15, 3.39). However, the number of recorded ex-
ercise sessions was positively associated with a change in maximal
grip strength in both right and left hands at both follow-ups (3
months: Bright¼ 0.2, 95% CI 0.01, 0.32; Bleft¼ 0.3, 95% CI 0.12, 0.45; 6
months: Bright ¼ 0.2, 95% CI 0.10, 0.38; Bleft ¼ 0.4, 95% CI 0.26, 0.60).
Adverse events
Three adverse events may possibly be related to the exercise
program: increased pain and inﬂammation in one ﬁnger (n ¼ 1);
increased pain and swelling of all ﬁngers (n ¼ 2). Five participants
with previous neck/shoulder problems experienced increased
neck/shoulder pain related to the three shoulder exercises (exercise
no. 1e3. in Table I), and one withdrew from the study.
Discussion
This is one of the ﬁrst large-scale RCT that has examined clinical
effectiveness of exercise therapy as a single treatment in people
with hand OA. The exercise programme was well tolerated, and
resulted in somewhat better hand activity performance in the PSFS
self-selected hand activity, but not for the standardized hand ac-
tivities in the FIHOA. The exercise intervention also led to minor
reductions in hand pain and hand stiffness, and improved global
assessment of disease activity, but therewas no increase inmaximal
grip strength or hand dexterity. Signiﬁcantly more participants in
the intervention group compared to the control group fulﬁlled the
OMERACT-OARSI responder criteria at 3 months. At the 6-month
follow-up, there were no signiﬁcant group differences in any
outcome. ITT and per protocol analyses showed comparable results.
The small improvements in our study on self-reportedmeasures
for hand activity performance, pain, stiffness, patient global
assessment, and the OMERACT-OARSI responder criteria are in
contrast toprevious research. Two recent, large studieswith amulti-disciplinary treatment program and joint protection & exercise in-
terventions13,14, respectively, and two previous, smaller studies on
exercise in people with hand OA16,17 showed no difference on self-
reported measures. While our intervention resulted in small im-
provements in self-reported measures, it failed to improve
performance-based outcomes like grip strength, which was the
intention of the exercise programme. The lack of gain on grip
strength and hand dexterity is in line with the two recent, large
studies13,14, whereas the two smaller studies reported modest
muscle strength improvements, and a third study (hand ﬂexibility
exercises and joint protection) showed a signiﬁcant increase in grip
strength10. However, there are large differences between these
studies in relation to sample sizes, additional treatment modalities,
type of exercises, exercise frequency and intensity. This study sam-
ple's baseline grip strength was about 80% of age and gender strat-
iﬁed reference values for grip strength in a Norwegian population-
based sample42, and hence closer to normal grip strength than re-
ported inadifferent studyamongNorwegianwomenwithhandOA2.
If the participants had been recruited during consultations rather
than from observational cohorts, their level of complaints and the
potential for improvement might have been higher.
According to previous research, beneﬁts of exercise therapy on
people with hip or knee OA are known to diminish over time if
exercise is discontinued43. In this study, the small difference be-
tween the two groups at 3-month follow-up (post-intervention)
was not present at 6-month follow-up. Although a relatively high
percentage of the intervention group reported that they had partly
continued to exercise post-intervention, this may be subject to
over-reporting of exercise habits44, or reﬂect a responder bias (i.e.,
thought they should have continued exercising).
In our study only one of the two outcome measures assessing
hand activity performance showed a signiﬁcant difference in
adjusted mean scores post-intervention between the two groups.
An explanation may be that while the participant-speciﬁed activity
limitation in the PSFS by deﬁnition will be a relevant activity, and
thereby likely to be more responsive, some of the ten standardized
FIHOA activities may be experienced as less relevant by the par-
ticipants. The use of two primary outcome measures is a frequently
mentioned problem as this may inﬂate the chance for false positive
conclusions and challenge the interpretation of inconclusive re-
sults. However, we decided to use both the FIHOA and the PSFS
although they measure the same aspect, because the FIHOA is
recommended by the OARSI45, and the PSFS ensured inclusion of
relevant activities. The sample calculations were performed for the
FIHOA as this outcome measure was hypothesized to be less
responsive than the PSFS. We considered that statistical signiﬁ-
cance was needed for both primary outcome measures, and
therefore no formal adjustment for type 1 error was necessary.
Overall, the clinical effectiveness of exercise in this trial may be
characterized as modest, and we cannot rule out that the difference
between the two groups post-intervention may be biased by
attention. The short-term improvements on self-reported mea-
sures and the lack of improvements on most performance-based
outcomes may support this. On the other hand, the performance-
based tests might not be suitable to capture small changes in this
study sample. Furthermore, the grip strength exercise and the
JAMAR Dynamometer measurement positions involve slightly
different ﬁnger joint ﬂexion angles, which might mean that the
muscles are trained and tested at somewhat different muscle
lengths. While close to half of the intervention group reported
clinically signiﬁcant improvements inmost self-reportedmeasures,
only a small proportion exceeded the MIC values for grip strength.
Different procedures with documented effects were performed
to minimize loss to follow-up and maximize intervention adher-
ence, i.e., booster group session in week 8, exercise diary and
N. Østerås et al. / Osteoarthritis and Cartilage 22 (2014) 1224e1233 1231telephone calls46. Although a large proportion was classiﬁed with
high adherence, the positive association between the number of
recorded sessions and gain in grip strength could indicate that if the
participants' exercise adherence had been higher, it might have
resulted in greater strength improvements. Even though the par-
ticipants received instructions on correct intensity and progression
during group sessions, the participants' actual intensity and/or
progression may have been too low. Future studies should inves-
tigate the effectiveness of higher dosage (higher actual intensity,
fewer repetitions, and 2e3 sets) and/or a pipe insulation tube with
larger diameter and more resistance.
By combining a population survey-recruited with a hospital-
recruited cohort, this study sample became more heterogeneous,
but also more representative for people with hand OA. However, as
most participants fulﬁlled the ACR criteria and had received the
diagnosis more than a decade ago, this study sample represented
people with a well established disease. Further, since there were
very few male participants, the study results can hardly be gener-
alized tomales. It is possible that subgroups of peoplewith hand OA
(i.e., those with <80% of normal grip strength), would have
beneﬁted more from the exercise programme investigated in this
study. Unfortunately, this study sample was too small for such sub-
group analyses.
The small loss of power represents a limitation in this study.
Although the attrition rate was lower (8%) than anticipated, we did
not manage to recruit the planned number of participants, which
might have increased the chance of a type 2 error. Compared to the
control group,more participants in the intervention groupwere lost
to follow-up. Four participants in the exercise group experienced
severe sickness unrelated to the study, whereas four considered the
exercise programme and follow-up measurements to be too time-
consuming. Further, this trial did not include a placebo interven-
tion, since no optimal solution for the content or the delivery of a
“sham exercise intervention” could be identiﬁed. We considered
that OA patient education as an attention control intervention could
possibly lead to increased hand activity, which in turnwould reduce
the contrast between the two groups, but other interventions not
related to OA management could have been considered.
Among the strengths of this trial is the close monitoring of
intervention adherence through the telephone calls and the
recording of exercise sessions in the diary during the intervention
period. Moreover, the thorough development of the exercise pro-
gramme following an evidence-based approach, combining evi-
dence from a systematic review on splints and hand exercises,
ACSM recommendations, involving patient research partners and
pilot testing, ensured a solid basis for the intervention. An addi-
tional strength is the combined use of validated-, self-reported
patient outcome measures and performance-based observational
tests recommended by the OARSI45 and the OMERACT47.
In conclusion, the exercise programme was well tolerated
among people with hand OA, but compared with usual care, the
exercise programme produced only small, short-term improve-
ments on self-reported measures and not on most performance-
based tests. Future studies should explore optimal grip strength
exercises, emphasize exercise intensity, and investigate whether
there is subgroups of people with hand OA that beneﬁt more than
others from doing exercises.
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